Skip to main content
Top
Published in: International Cancer Conference Journal 2/2019

01-04-2019 | Vulvectomy | Case report

Adenocarcinoma of intestinal type of the vulva

Authors: Tomoko Kurita, Yusuke Matuura, Masanori Hisaoka, Toru Hachisuga

Published in: International Cancer Conference Journal | Issue 2/2019

Login to get access

Abstract

Primary adenocarcinoma of the vulva is a rare disease, and usually arises in a Bartholin gland or occurs in association with Paget’s disease. Furthermore, adenocarcinoma of intestinal type of the vulva is an extremely rare neoplasm, and few cases have been reported. The appropriate treatment for optimal prognosis is unclear. We report a case of adenocarcinoma of intestinal type of the vulva occurring in a 63-year-old female. The tumor was found near the urethra, and biopsy specimen showed a proliferation of signet ring cells embedded in an abundant myxoid stroma and irregular tubular structures of atypical columnar epithelium. An extensive workup showed no metastases. Local excision with a 2-cm lesion in the vulva side, bilateral superficial inguinal lymph node dissection and Cloquet lymph node biopsy were performed. Cancer cells contained mucinous materials in the cytoplasm, which exhibited diffuse positive staining for cytokeratin 20 and CDX2. The final pathologic diagnosis was adenocarcinoma of intestinal type of the vulva (pT1bN0M0). The patient received adjuvant external irradiation because of positive urethral surgical margin. She is well 1 year after therapy. Immunohistochemical staining for cytokeratin 20 and polyclonal CDX2 is helpful with investigation of adenocarcinoma of intestinal type, but long-term prognosis remains unclear.
Literature
1.
go back to reference Wilkinson EJ (2011) Premalignant tumors of the vulva. In Kurman RJ (ed) Blaustein’s pathology of the female genital tract. 6th ed. Springer, New York, pp 55–103CrossRef Wilkinson EJ (2011) Premalignant tumors of the vulva. In Kurman RJ (ed) Blaustein’s pathology of the female genital tract. 6th ed. Springer, New York, pp 55–103CrossRef
2.
go back to reference Novak ER, Woodruff JD (1974) Gynecologic and obstetrics pathology with clinical and endocrine relations. 7th ed. Saunders, Philadelphia Novak ER, Woodruff JD (1974) Gynecologic and obstetrics pathology with clinical and endocrine relations. 7th ed. Saunders, Philadelphia
3.
go back to reference Sui Y, Zou J, Batchu N et al (2016) Primary mucious adenocarcinoma of the vulva: a case report and review of the literature. Mol clin oncol 4:545–548CrossRefPubMedPubMedCentral Sui Y, Zou J, Batchu N et al (2016) Primary mucious adenocarcinoma of the vulva: a case report and review of the literature. Mol clin oncol 4:545–548CrossRefPubMedPubMedCentral
4.
go back to reference WHO Classification of Tumors of Female Reproductive Organs. 4th edition. IARC 2014 Press, Lyon WHO Classification of Tumors of Female Reproductive Organs. 4th edition. IARC 2014 Press, Lyon
5.
go back to reference Tiltman AJ, Knutzen VK (1978) Primary adenocarcinoma of the vulva originating in misplaced cloacal tissue. Obstet Gynecol 51: 30 s–3 s Tiltman AJ, Knutzen VK (1978) Primary adenocarcinoma of the vulva originating in misplaced cloacal tissue. Obstet Gynecol 51: 30 s–3 s
6.
go back to reference Kennedy JC, Majmudar B (1993) Primary adenocarcinoma of the vulva, possibly cloacogenic: a report of two cases. J Reprod Med 38:113–116PubMed Kennedy JC, Majmudar B (1993) Primary adenocarcinoma of the vulva, possibly cloacogenic: a report of two cases. J Reprod Med 38:113–116PubMed
7.
go back to reference Zaidi SN, Conner MG (2001) Primary vulvar adenocarcinoma of cloacogenic origin. South Med J 94:744–746CrossRefPubMed Zaidi SN, Conner MG (2001) Primary vulvar adenocarcinoma of cloacogenic origin. South Med J 94:744–746CrossRefPubMed
8.
go back to reference Dube V, Veilleux C, Plante M et al (2004) Primary villoglandular adenocarcinoma of cloacogenic origin of the vulva. Hum Pathol 35:377–379CrossRefPubMed Dube V, Veilleux C, Plante M et al (2004) Primary villoglandular adenocarcinoma of cloacogenic origin of the vulva. Hum Pathol 35:377–379CrossRefPubMed
9.
go back to reference Ghamande SA, Kasznica J, Griffiths CT, Finkler NJ, Hamid AM (1995) Mucinous adenocarcinomas of the vulva. Gynecol Oncol 57:117–120CrossRefPubMed Ghamande SA, Kasznica J, Griffiths CT, Finkler NJ, Hamid AM (1995) Mucinous adenocarcinomas of the vulva. Gynecol Oncol 57:117–120CrossRefPubMed
10.
go back to reference Rodriguez A, Isaac MA, Hidalgo E, Marquez B, Nogales FF (2001) Villoglandular adenocarcinoma of the vulva. Gynecol Oncol 83:409–411CrossRefPubMed Rodriguez A, Isaac MA, Hidalgo E, Marquez B, Nogales FF (2001) Villoglandular adenocarcinoma of the vulva. Gynecol Oncol 83:409–411CrossRefPubMed
11.
go back to reference Cormio G, Carriero C, Loizzi V, Gissi F, Leone L, Putignano G et al (2012) “Intestinal-type” mucinous adenocarcinoma of the vulva: a report of two cases. Eur J Gynaecol Oncol 33:433–435PubMed Cormio G, Carriero C, Loizzi V, Gissi F, Leone L, Putignano G et al (2012) “Intestinal-type” mucinous adenocarcinoma of the vulva: a report of two cases. Eur J Gynaecol Oncol 33:433–435PubMed
12.
13.
go back to reference Rodriguez A, Isaac MA, Hidalgo E et al (2001) Villoglandular adenocarcinoma of the vulva. Gynecol Oncol 83:409–411CrossRefPubMed Rodriguez A, Isaac MA, Hidalgo E et al (2001) Villoglandular adenocarcinoma of the vulva. Gynecol Oncol 83:409–411CrossRefPubMed
14.
go back to reference Willen R, Bekassay Z, Carlen B et al (1999) Cloacogenic adenocarcinoma of the vulva. Gynecol Oncol 74:298–301CrossRefPubMed Willen R, Bekassay Z, Carlen B et al (1999) Cloacogenic adenocarcinoma of the vulva. Gynecol Oncol 74:298–301CrossRefPubMed
16.
go back to reference Arvas M, Kose F, Gezer A et al (2005) Radical versus conservative surgery for vulvar carcinoma. Int J Gynecol Obstet 88:127–133CrossRef Arvas M, Kose F, Gezer A et al (2005) Radical versus conservative surgery for vulvar carcinoma. Int J Gynecol Obstet 88:127–133CrossRef
17.
go back to reference Chan JK, Sugiyama V, Pham H et al (2007) Margin distance and other clinico-pathologic prognosis factors in vulvar carcinoma: a multivariate analysis. Gynecol Oncol 104:636–641CrossRefPubMed Chan JK, Sugiyama V, Pham H et al (2007) Margin distance and other clinico-pathologic prognosis factors in vulvar carcinoma: a multivariate analysis. Gynecol Oncol 104:636–641CrossRefPubMed
18.
go back to reference Faul CM, Mirmow D, Huang Q et al (1997) Adjuvant radiation for vulvar carcinoma: improved local control. Int J Radiat Oncol Biol Phys 38:381–389CrossRefPubMed Faul CM, Mirmow D, Huang Q et al (1997) Adjuvant radiation for vulvar carcinoma: improved local control. Int J Radiat Oncol Biol Phys 38:381–389CrossRefPubMed
19.
go back to reference Tepeoglu M, Uner H, Haberal AN et al (2016) Cloacogenic adenocarcinoma of the vulva: a case report and review of the literature. Turkish J Pathol 34(3):255–258 Tepeoglu M, Uner H, Haberal AN et al (2016) Cloacogenic adenocarcinoma of the vulva: a case report and review of the literature. Turkish J Pathol 34(3):255–258
Metadata
Title
Adenocarcinoma of intestinal type of the vulva
Authors
Tomoko Kurita
Yusuke Matuura
Masanori Hisaoka
Toru Hachisuga
Publication date
01-04-2019
Publisher
Springer Singapore
Published in
International Cancer Conference Journal / Issue 2/2019
Electronic ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-019-00361-x

Other articles of this Issue 2/2019

International Cancer Conference Journal 2/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine